Immediate Impact
3 from Science/Nature 24 standout
Citing Papers
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Rick Oerlemans being referenced
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rick Oerlemans | 214 | 80 | 44 | 64 | 12 | 322 | |
| Sílvia A. Martins | 200 | 129 | 48 | 65 | 7 | 341 | |
| Duc-Hung Pham | 115 | 92 | 35 | 56 | 17 | 323 | |
| Stuart Firth‐Clark | 243 | 132 | 52 | 29 | 12 | 341 | |
| Xinben Zhang | 172 | 124 | 22 | 95 | 18 | 290 | |
| Jerry O. Ebalunode | 237 | 104 | 74 | 42 | 20 | 352 | |
| V. Talibov | 262 | 51 | 53 | 44 | 17 | 337 | |
| Dharshini Gopal | 173 | 63 | 27 | 48 | 13 | 329 | |
| Raudah Lazim | 264 | 80 | 53 | 38 | 18 | 371 | |
| P. J. WHITTLE | 121 | 41 | 29 | 95 | 10 | 324 | |
| D. Fearon | 184 | 148 | 45 | 142 | 14 | 364 |
All Works
Login with ORCID to disown or claim papers
Loading papers...